de Boer, Rudolf A. https://orcid.org/0000-0002-4775-9140
Article History
Accepted: 6 June 2023
First Online: 26 July 2023
Conflict of interest
: Dr. De Boer has received research grants and/or fees from AstraZeneca, Abbott, Boehringer Ingelheim, Cardior Pharmaceuticals GmbH, Ionis Pharmaceuticals, Inc., Novo Nordisk, and Roche; and has had speaker engagements with Abbott, AstraZeneca, Bayer, Bristol Myers Squibb, Novartis, and Roche.